TIGIT and melanoma: Importantly, in one recent study of melanoma, it was shown that the TIGIT blockade primarily acts on NK cells to inhibit tumor growth, as NK-cell depletion resulted in an abrogation of the antitumor effects of the TIGIT blockade [12].